Table 2. Multivariate logistic regression analysis for mortality.

Variables		Crude OR	95% CI	P value	Adjusted OR	95% CI	P value
In-hospital mortality
	Age	1.02	1.01–1.04	< 0.001	1.02	1.01–1.03	0.004
	Previous stroke/TIA	0.83	0.64–1.09	0.187	0.79	0.58–1.07	0.132
	Hyperlipidemia	1.13	0.88–1.45	0.323	1.23	0.93–1.63	0.152
	Atrial fibrillation	1.36	1.06–1.74	0.014	1.12	0.77–1.64	0.560
	Coronary artery disease	1.51	1.17–1.95	0.002	1.58	1.19–2.11	0.002
	Initial NIHSS	1.06	1.04–1.07	< 0.001	1.05	1.03–1.07	< 0.001
	Pre-stroke mRS 1–5	1.20	0.92–1.56	0.176	1.08	0.80–1.45	0.618
	Thrombolytic therapy	1.14	0.89–1.46	0.308	1.00	0.76–1.30	0.975
	Without neurointensivists	1.64	1.18–2.26	0.003	1.59	1.13–2.25	0.008
Mortality at 3 months
	Age	1.03	1.03–1.04	< 0.001	1.03	1.02–1.04	< 0.001
	Previous stroke/TIA	0.93	0.74–1.17	0.511	0.79	0.61–1.02	0.072
	Hyperlipidemia	1.04	0.84–1.29	0.703	1.029	0.80–1.31	0.854
	Atrial fibrillation	1.39	1.12–1.71	0.003	1.09	0.78–1.52	0.617
	Coronary artery disease	1.42	1.13–1.79	0.002	1.37	1.06–1.76	0.015
	Initial NIHSS	1.04	1.02–1.05	< 0.001	1.03	1.02–1.05	< 0.001
	Pre-stroke mRS 1–5	1.44	1.15–1.83	0.002	1.22	0.95–1.58	0.125
	Thrombolytic therapy	0.86	0.70–1.07	0.180	0.79	0.63–1.00	0.049
	Without neurointensivists	1.58	1.22–2.05	< 0.001	1.48	1.12–1.95	0.005

OR = odds ratio, CI = confidence interval, TIA = transient ischemic attack, NIHSS = National Institute of Health Stroke Scale, mRS = modified Rankin scale.

Adjusting for without neurointensivist, age, gender, previous stroke/TIA, hyperlipidemia, diabetes mellitus, hypertension, smoking, atrial fibrillation, coronary artery disease, initial NIHSS, previous mRS, thrombolytic therapy, and stroke subtypes.